Lung cancer patients to benefit from revolutionary new drug on NHS
Thousands of lung cancer patients in England will be fast-tracked a ground-breaking new drug which can significantly reduce the risk of cancer returning, thanks to a deal brokered by NHS England. The MHRA has now approved the effective therapy, atezolizumab, to treat non-small cell lung cancer (NSCLC), with more than 850 patients in England expected […]